iOmx Therapeutics
- Website
- iomx.com
- Total Funding
- $122.3M
- Last Round
- $75.3M Series BOct 2021
- Rounds
- 2
About
Immune checkpoint targets for next-gen cancer immunotherapy
Summary
It has raised $122.3M in total across 2 rounds, most recently a $75.3M Series B round in Oct 2021. Investors include MIG Capital, MPM Capital and Wellington Management.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
